NiceRx vs TeleClinic
Two GLP-1 desks, one scoreboard. We put NiceRx and TeleClinic head-to-head on the published Brief Score — the same six factors, scored the same way.
NiceRx
The verdict
NiceRx takes this head-to-head.
NiceRx scores 86 to 75 on our six-factor Brief Score — An established medication-access brand, now LegitScript-certified and nationwide on both molecules.
That doesn't make TeleClinic a bad call — it's best for readers who want transparent, cash-pay compounded glp-1 from a named 503a pharmacy across 47 states. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| NiceRx | TeleClinic | |
|---|---|---|
| Brief Score | 86/100 (B) | 75/100 (C) |
| Semaglutide | $199/mo | From $199/mo (compounded) |
| Tirzepatide | $299/mo | From $299/mo (compounded) |
| Coverage | All 50 states | 47 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
NiceRx: $199 sema / $299 tirz nationwide; LegitScript-certified, established operator.
TeleClinic: New to the tracker on 1 August 2026. The published line reads From $199/mo (compounded) at our first reading; there is no earlier reading of ours to compare it against yet.
● Not sold on either?
CoreAge Rx tops the whole ranking at 94/100.
The steadiest desk in the ranking: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.